Frost & Sullivan Acclaims SUITESTENSA, the EBIT's Technically Advanced Cardiovascular Information System Integration Platform
By offering an advanced software system for the integrated workflow management of the Enterprise IT diagnostic process, SUITESTENSA platform can reduce costs and time involved, enhancing the quality of clinical diagnosis.
MOUNTAIN VIEW, California, Nov. 16, 2015 /PRNewswire/ -- Based on its recent analysis of the cardiovascular information system (CVIS) market, Frost & Sullivan recognises EBIT with the 2015 European Frost & Sullivan Award for Technology Leadership. EBIT's SUITESTENSA is a comprehensive IT system that integrates the patient tracking and reporting capabilities of a CVIS with the image storing capacity of a picture archiving and communication system (PACS). Its peculiar strength is a tightly integrated multi-modality IT solutions that automatically stores cardiovascular test results onto a single platform, helping doctors to access and track both current and previous patient reports, images, and test results to develop a thorough and valid diagnostic plan.
Photo - http://photos.prnewswire.com/prnh/20151113/287213
Born first within the cardiovascular department, SUITESTENSA is now an enterprise IT system that shares information between hospital departments and even hospitals, allowing seamless due to its aligned archiving server systems. Featuring an effective equipment vendor-agnostic profile, SUITESTENSA has a broad compatibility and interoperability of all software, technologies, and modalities involved, so that it has a multi-departmental approach managing diagnostics from Cardiac Catheterization, Electrophysiology, Echocardiography, Electrocardiography, General Cardiology, Cardiovascular Surgery, Interventional Cardiology and Endovascular Surgery.
"Due to the integration of different reporting methods and images—all collected on a single cardiology patient folder—SUITESTENSA enhances multi-disciplinary health services and multi-territorial data sharing, simplifying information mobility and telemedicine challenges;" said Frost & Sullivan Research Analyst Michelle Reich, "Moreover, its multi-platform architecture runs different operating systems and programming environments, while a cross-platform web application is accessible via various web browsers".
Focusing on patients' preventive, diagnostic, and therapeutic well-being, EBIT integrates other Esaote Group's (EBIT's parent company) software products: Pie Medical Imaging Cardiovascular Angiography Analysis System (PMI CAAS), to perform diagnosis and planning of treatments of coronary arteries, heart chambers and peripheral vessels via X-ray, MRI, IVUS, and OCT images; and 3mensio Structural Heart software to support planning of TAVI and mitral procedures, sizing, and visualization in CT images.
"EBIT's primary commercialisation focus has been its home market of Italy, where it currently holds more than 50 percent of the market share," noted Frost & Sullivan Research Analyst Siddharth Saha. "Even when SUITESTENSA expanded into different markets such as Brazil, Colombia, Argentina, China, Germany and parts of Eastern Europe, EBIT continued to offer full technological support for the platform by building and maintaining support facilities in those countries or regions."
SUITESTENSA's technically advanced integration, user-friendly interface and commitment to customer support has fast tracked EBIT's rise in the European CVIS market. Krishna Srinivasan, Global President and Managing Partner, Frost & Sullivan, sums up, "Technology-rich companies with strong commercialisation strategies benefit from the increased demand for high-quality, technologically innovative products. We are pleased to recognise EBIT for its abiding investment and continuous focus in leveraging technology to drive customer value and business impact."
Each year, Frost & Sullivan presents this award to a company that has developed a pioneering technology that not only enhances current products but also enables the development of newer products and applications. The award recognises the high market acceptance potential of the recipient's technology.
Frost & Sullivan Best Practices awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.
About EBIT
EBIT is the Esaote's Healthcare IT Company focused on developing and selling RIS CVIS PACS software for integrated workflows in hospital enterprise processes.
Its SUITESTENSA is the most complete software suite for workflow and medical image management, implementing Structured Report, 3D/4D image processing, multiplatform Web & Mobile PACS Solutions.
SUITESTENSA application domains encompass a wide range of specialities, including Radiology and Interventional Radiology, Cardiac Catheterization, Echocardiography, Electrocardiography, Electrophysiology, Cardiovascular Surgery, Nuclear Medicine, Radiotherapy, Breast Imaging, Orthopaedics.
EBIT's mission is to deliver cutting-edge information technology to assist health operators, anticipating their evolving needs. EBIT aims at supporting healthcare professionals with streamlined filmless and paperless workflows, advanced clinical applications and effective integration of all software and modalities, thanks to an equipment vendor-agnostic approach.
The benefits for citizens are huge simplifications of medical services access, the realization of their Electronic Medical Record, and qualitative clinical diagnosis. The benefits for healthcare providers are streamlined organization, reduced hospitalization and costs, increased diagnostic accuracy, optimized services via the web and mobile devices.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.
Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
- The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
- The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organisation prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?
Contact Us: Start the discussion
Subscribe: Newsletter on "the next big thing"
Register: Gain access to visionary innovation
Contact:
Adelaide Mendes
Best Practices Group
Frost & Sullivan
Tel.: +44-(0)-207-9157869
E-mail: adelaide.mendes@frost.com
Share this article